Form 4: Marimed CFO Mario Pinho Reports Acquisition of Restricted Stock Units

Mario Pinho, CFO of Marimed Inc., reports the acquisition of 48,226 Restricted Stock Units (RSUs) that will vest in three equal installments.

Summary

• On May 9, 2025, Mario Pinho, the Chief Financial Officer of Marimed Inc., reported acquiring 48,226 Restricted Stock Units (RSUs).
• These RSUs convert to shares of common stock on a one-for-one basis.
• The RSUs will vest in three equal installments on June 15, 2025, September 15, 2025, and December 15, 2025, as per the agreement between Marimed Inc. and Mr. Pinho.
• Following the reported transaction, Mr. Pinho directly owns 35,009 shares of common stock and 48,246 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by the CFO suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of RSUs by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects standard practices for incentivizing and retaining key personnel.

Comparison to Industry Standards

• Granting restricted stock units (RSUs) to executives is a common practice among publicly traded companies to align management's interests with those of shareholders.
• Vesting schedules, such as the three-installment plan described, are typical for RSUs to encourage long-term commitment.
• Companies like Canopy Growth, Aurora Cannabis, and Tilray, which operate in the cannabis industry like Marimed, also utilize stock-based compensation as part of their executive compensation packages.

Stakeholder Impact

• The vesting of RSUs will increase the number of shares outstanding, potentially diluting existing shareholders' ownership.

Key Dates

Keywords

Marimed Inc., Mario Pinho, CFO, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, MRMD